The gut–liver axis has been increasingly recognized as a major autoimmunity modulator.
However, the implications of intestinal barrier in the pathogenesis of autoimmune hepatitis …

Autoimmune hepatitis (AIH) is a liver disease characterized by chronic liver inflammation.
The intestinal barrier and microbiome play critical roles in AIH progression. AIH treatment …

Autoimmune hepatitis (AIH) is an immune-mediated inflammatory liver disease with unclear
pathogenesis. The gut microbiota and intestinal barrier play an essential role in AIH …

Autoimmune hepatitis (AIH) is a chronic immune-mediated liver disease that is distributed
globally in all ethnicities with increasing prevalence. If untreated, the disease will lead to …

Autoimmune hepatitis (AIH) is a serious chronic liver disease that may last for decades and
eventually develop into cirrhosis and liver failure. In recent years, people have paid more …

Autoimmune hepatitis (AIH) is an immune-mediated chronic inflammatory liver disease, and
its pathogenesis is not fully understood. Our previous study discovered that receptor …

Intestinal homeostasis depends on complex interactions between the gut microbiota and
host immune system. Emerging evidence indicates that the intestinal microbiota is a key …

Autoimmune hepatitis (AIH) is an immune-mediated inflammatory liver disease of uncertain
cause. Accumulating evidence shows that gut microbiota and intestinal barrier play …

In healthy settings, the gut–liver axis allows host–microbiota communications and mediates
immune homeostasis through bidirectional regulation. Meanwhile, in diseases, gut …

The gut microbiota consists of a dynamic multispecies community of bacteria, fungi, archaea,
and protozoans, playing a fundamental role in the induction, training, and function of the …